Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly Other Non-Current Liabilities of $1.3 million for Q1 2026, up 49.83% year-over-year from $875000.0 in Q1 2025, and down 10.69% quarter-over-quarter from $1.5 million in Q4 2025.
Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Other Non-Current Liabilities for 17 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 49.83% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 49.83% YoY), while the FY2025 annual figure was $1.5 million, up 76.65% from the prior year.
- Other Non-Current Liabilities eased to $1.3 million in Q1 2026 per LMAT's latest filing, from $1.5 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.4 million in Q3 2022 and bottomed at $187000.0 in Q1 2023.
- Historically, Other Non-Current Liabilities has averaged $1.2 million across 5 years, with a median of $933000.0 in 2025.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities surged 1668.38% — and 2024, when it sank 87.69%.
- Lemaitre Vascular's Other Non-Current Liabilities stood at $2.2 million in 2022, then increased by 4.66% to $2.3 million in 2023, then tumbled by 63.36% to $831000.0 in 2024, then soared by 76.65% to $1.5 million in 2025, then retreated by 10.69% to $1.3 million in 2026.
- Business Quant data shows LMAT's Other Non-Current Liabilities at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $933000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.46 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 933,000.00 |
| Jun 30, 2025 | 934,000.00 |
| Mar 31, 2025 | 875,000.00 |
| Dec 31, 2024 | 831,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Jun 30, 2024 | 2.18 Mn |
| Mar 31, 2024 | 594,000.00 |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 578,000.00 |
| Mar 31, 2023 | 187,000.00 |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | 2.41 Mn |
| Jun 30, 2022 | 691,000.00 |
| Mar 31, 2022 | 766,000.00 |
| Dec 31, 2021 | 141,000.00 |
| Sep 30, 2021 | 136,000.00 |